Form 4: HCA Healthcare CEO Gifts 14,830 Shares
Insider Transaction Report
HCA Healthcare CEO Samuel N. Hazen reported gifting 14,830 shares of common stock on November 14, 2025, under a Rule 10b5-1 plan.
Summary
- Samuel N. Hazen, CEO and Director of HCA Healthcare, Inc. (HCA), reported a gift of common stock.
- On November 14, 2025, Mr. Hazen disposed of 14,830 shares of HCA common stock via a gift (transaction code 'G') at a price of $0 per share.
- The transaction was made pursuant to a Rule 10b5-1(c) plan.
- Following this transaction, Mr. Hazen directly beneficially owns 32,276 shares of common stock.
- Indirect beneficial ownership includes 14,979 shares by HD Trust, 16,731 shares by 2023 GST Trust, 93,088 shares by 2023 Trust, 178,289 shares by 2024 GRAT, 200,000 shares by 2025 GRAT, and 813,320 shares by LP.
Sentiment
Score: 5
Explanation: The filing reports a routine insider gift of shares, which is a neutral event for company operations and stock valuation.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding HCA Healthcare's future performance or outlook.
Industry Context
Insider transactions, such as gifts of shares, are common occurrences across all industries and are typically related to personal financial planning or estate management rather than direct operational performance or strategic shifts within the healthcare industry.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Disclosure Practice | The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan designed to comply with insider trading laws. | 11/14/2025 | This demonstrates adherence to corporate governance best practices for insider trading, providing an affirmative defense against claims of trading on material non-public information. |
Related Party Transactions
- The disposition of shares was a gift to various trusts (HD Trust, 2023 GST Trust, 2023 Trust, 2024 GRAT, 2025 GRAT) and an LP, which are typically considered related parties to the reporting person for estate planning purposes.
Stakeholder Impact
- Shareholders: Minimal direct impact, as the transaction is a gift and not a sale for cash, suggesting personal estate planning rather than a change in management's view of the company's prospects.
- Management: Reflects personal financial and estate planning by the CEO.
Key Dates
| Date | Description |
|---|---|
| 11/14/2025 | Date of earliest transaction where 14,830 shares of common stock were gifted. |
| 11/18/2025 | Date the Form 4 was signed by Kevin A. Ball, Attorney-in-Fact for Samuel N. Hazen. |
Recommendation
holdA Form 4 filing reporting a gift of shares by an insider is a routine disclosure and does not typically impact the fundamental investment thesis or warrant a change in recommendation. The transaction is likely for estate planning purposes and does not reflect a change in the company's operational performance or outlook.
Keywords
HCA Healthcare, Samuel N. Hazen, Form 4, Insider Transaction, Stock Gift, CEO, Beneficial Ownership, Common Stock, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.